✦ LIBER ✦

Pharmacokinetics and toxicity of etoposide in combination with carboplatin in patients with small cell lung cancer (SCLC)

✍ Scribed by Strömgren, A; Sørensen, BT; Jakobsen, P; Jakobsen, A

Book ID: 122440215
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 153 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91216-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin and etoposide (CE) in newly

Carboplatin and etoposide (CE) in newly diagnosed patients with small cell lung cancer (SCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Etoposide and high dose carboplatin in p

Etoposide and high dose carboplatin in previously untreated patients with small cell lung cancer (SCLC)

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Carboplatin in combination with etoposid

Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC)

✍ P. Weynants; Y. Humblet; A. Bosly; D. Schallier; P. Duprez; F. Majois; M. Beaudu 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 320 KB

Carboplatin in combination with etoposid

Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC)

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Carboplatin in Combination with Bendamus

Carboplatin in Combination with Bendamustine in Previously Untreated Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

✍ Dr Wolf Köster, G. Stamatis, A. Heider, K. Avramidis, H. Wilke, J.A. Koch, M. St 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 104 KB

Topotecan–carboplatin–etoposide combinat

Topotecan–carboplatin–etoposide combination as 1st line treatment in patients with small cell lung cancer

✍ Zarogoulidis, K.; Mylonaki, E.; Kakavelas, P.; Zarogoulidis, P.; Tsiouda, Th.; R 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 258 KB